Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial-Reference-Cited by-同舟云学术

Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial

Published:2014-04 Issue:4 Volume:32 Page:334-341
ISSN:0735-6757
Container-title:The American Journal of Emergency Medicine
language:en
Short-container-title:The American Journal of Emergency Medicine

Author:

Travaglino Francesco,Russo Veronica,De Berardinis Benedetta,Numeroso Filippo,Catania Pamela,Cervellin Gianfranco,Nigra Stefano Geniere,Geraci Francesco,Bressan Maria Antonietta,Guerrini Stefania,Cavazza Mario,Folli Christian,Monzani Valter,Battista Stefania,Mengozzi Giulio,Noto Paola,Carpinteri Giuseppe,Semplicini Andrea,Stella Federica,Ingrassia Stella,Moscatelli Paolo,Giuntini Patrizia,Salerno Gerardo,Cardelli Patrizia,Di Somma Salvatore

Publisher

Elsevier BV

Subject

Emergency Medicine,General Medicine

Reference43 articles.

1. Role of biomarkers in patients with dyspnea;Gori;Eur Rev Med Pharmacol Sci,2011

2. Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications;Farmakis;Congest Heart Fail,2008

3. State of the art: using natriuretic peptide levels in clinical practice;Maisel;Eur J Heart Fail,2008

4. Utility of procalcitonin (PCT) and mid-regional pro-adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in emergency department (ED). A comparison with APACHE II score;Travaglino;BMC Infect Dis,2012

5. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial;Möckel;Emerg Med J,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologically Active Adrenomedullin (bio-ADM) is of Potential Value in Identifying Congestion and Selecting Patients for Neurohormonal Blockade in Acute Dyspnea;The American Journal of Medicine;2022-07

2. Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study;PLOS ONE;2019-06-17

3. Biomarkers in heart failure: the past, current and future;Heart Failure Reviews;2019-06-10

4. Biomarkers in Shortness of Breath;Biomarkers in Cardiovascular Disease;2019

5. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study;BMJ Open;2018-11